118 related articles for article (PubMed ID: 15633996)
1. Phenazine 5,10-dioxide derivatives as hypoxic selective cytotoxins.
Cerecetto H; González M; Lavaggi ML; Azqueta A; López de Cerain A; Monge A
J Med Chem; 2005 Jan; 48(1):21-3. PubMed ID: 15633996
[TBL] [Abstract][Full Text] [Related]
2. Phenazine 5,10-dioxide derivatives as hypoxic selective cytotoxins: Part II. Structure-activity relationship studies.
Cerecetto H; González M; Lavaggi ML; Aravena MA; Rigol C; Olea-Azar C; Azqueta A; de Cerain AL; Monge A; Bruno AM
Med Chem; 2006 Sep; 2(5):511-21. PubMed ID: 17017991
[TBL] [Abstract][Full Text] [Related]
3. Structural modifications on the phenazine N,N'-dioxide-scaffold looking for new selective hypoxic cytotoxins.
Lavaggi ML; Nieves M; Cabrera M; Olea-Azar C; López de Ceráin A; Monge A; Cerecetto H; González M
Eur J Med Chem; 2010 Nov; 45(11):5362-9. PubMed ID: 20846761
[TBL] [Abstract][Full Text] [Related]
4. Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation.
Lavaggi ML; Cabrera M; Aravena Mde L; Olea-Azar C; López de Ceráin A; Monge A; Pachón G; Cascante M; Bruno AM; Pietrasanta LI; González M; Cerecetto H
Bioorg Med Chem; 2010 Jun; 18(12):4433-40. PubMed ID: 20471844
[TBL] [Abstract][Full Text] [Related]
5. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
[TBL] [Abstract][Full Text] [Related]
6. Novel Cu(II) quinoxaline N1,N4-dioxide complexes as selective hypoxic cytotoxins.
Torre MH; Gambino D; Araujo J; Cerecetto H; González M; Lavaggi ML; Azqueta A; López de Cerain A; Vega AM; Abram U; Costa-Filho AJ
Eur J Med Chem; 2005 May; 40(5):473-80. PubMed ID: 15893021
[TBL] [Abstract][Full Text] [Related]
7. Antitumoral effect of phenazine N5,N10-dioxide derivatives on Caco-2 cells.
Pachón OG; Azqueta A; Lavaggi ML; López de Cerain A; Creppy E; Collins A; Cerecetto H; González M; Centelles JJ; Cascante M
Chem Res Toxicol; 2008 Aug; 21(8):1578-85. PubMed ID: 18553946
[TBL] [Abstract][Full Text] [Related]
8. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D
Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490
[TBL] [Abstract][Full Text] [Related]
10. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part II.
Cerecetto H; González M; Onetto S; Saenz P; Ezpeleta O; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):247-58. PubMed ID: 15095418
[TBL] [Abstract][Full Text] [Related]
11. 2-Alkylsulfonyloxy-3-hydroxy-1,4-naphthoquinones: a novel class of radio- and chemosensitizers of V79 cells.
Hatzigrigoriou E; Papadopoulou MV; Shields D; Bloomer WD
Oncol Res; 1993; 5(1):29-36. PubMed ID: 8369573
[TBL] [Abstract][Full Text] [Related]
12. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
[TBL] [Abstract][Full Text] [Related]
13. Nitro analogues of chlorambucil as potential hypoxia-selective anti-tumour drugs.
Palmer BD; Wilson WR; Denny WA
Anticancer Drug Des; 1990 Nov; 5(4):337-49. PubMed ID: 2291774
[TBL] [Abstract][Full Text] [Related]
14. Pyrimido[1,2-a]quinoxaline 6-oxide and phenazine 5,10-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi.
Lavaggi ML; Aguirre G; Boiani L; Orelli L; García B; Cerecetto H; González M
Eur J Med Chem; 2008 Aug; 43(8):1737-41. PubMed ID: 18068272
[TBL] [Abstract][Full Text] [Related]
15. Differential enzymatic reductions governing the differential hypoxia-selective cytotoxicities of phenazine 5,10-dioxides.
Lavaggi ML; Cabrera M; González M; Cerecetto H
Chem Res Toxicol; 2008 Sep; 21(9):1900-6. PubMed ID: 18661957
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as potential hypoxic cytotoxins and DNA-binders.
Cerecetto H; González M; Risso M; Seoane G; López de Ceráin A; Ezpeleta O; Monge A; Suescun L; Mombrú A; Bruno AM
Arch Pharm (Weinheim); 2000 Nov; 333(11):387-93. PubMed ID: 11129981
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers.
Papadopoulou MV; Rosenzweig HS; Bloomer WD
Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of some steroidal oximes as cytotoxic agents: structure/activity studies (I).
Cui JG; Fan L; Huang LL; Liu HL; Zhou AM
Steroids; 2009 Jan; 74(1):62-72. PubMed ID: 18838084
[TBL] [Abstract][Full Text] [Related]
20. NLNQ-1, a 2-[3-(2-nitro-1-imidazolyl) propylamino]-3-chloro-1,4-naphthoquinone, as a hypoxia-selective cytotoxin and radiosensitizer.
Papadopoulou MV; Bloomer WD
In Vivo; 2008; 22(3):285-8. PubMed ID: 18610737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
